- 期刊
- OpenAccess
Extended Release Niacin-Laropiprant in Patients with Hypercholesterolemia or Mixed Dyslipidemias Improves Clinical Parameters
並列摘要
The progression of atherosclerosis remains a major cause of morbidity and mortality. Plaque formation is an immunological response driven by a number of risk factors, and reduction of risk is the primary goal of treatment. The role of LDL-C is well established and statins have proved effective drugs, although the relative risk reduction is only around 30%. The importance of other factors-notably low HDL-C and high TGs-has become increasingly clear and the search for alternative strategies continues. Niacin is particularly effective in achieving normalization of HDL-C but is clinically underutilized due to the side effect of cutaneous flushing. The discovery that flushing is mediated by mechanisms distinct from the lipid-lowering effects has led to the development of combination drugs with reduced side effects. This review considers the evidence regarding the clinical efficacy of extended-release niacin and the DP1 antagonist laropiprant in the treatment of hypercholesterolemia and mixed dyslipidemias.
延伸閱讀
- Marfatia, R., White, W. B., & Schumacher, H. (2012). Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension. International Journal of Hypertension, 2012(), 941-947. https://doi.org/10.1155/2012/976828
- Wang, K. F., Wu, C. H., Chang, C. C., Chen, L. C., Wang, K. L., Lu, T. M., Lin, S. J., & Chiang, C. E. (2017). Determinants of Treatment Modification in Hypercholesterolemic Patients. Acta Cardiologica Sinica, 33(2), 156-164. https://doi.org/10.6515/ACS20161215A
- Dedeepiya, V. D., Sivaraman, G., Venkatesh, A. P., Preethy, S., & Abraham, S. J. K. (2012). Potential Effects of Nichi Glucan as a Food Supplement for Diabetes Mellitus and Hyperlipidemia: Preliminary Findings from the Study on Three Patients from India. Case Reports in Medicine, 2012(), 111-115-321. https://doi.org/10.1155/2012/895370
- 朱志生（2004）。Effects on Soluble CD40L and Adipocytokines after Therapy and Withdrawal of Atorvastatin in Patients with Hypercholesterolemia〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2903200614002223
- Sagara, M., Njelekela, M., Teramoto, T., Taguchi, T., Mori, M., Armitage, L., Birt, N., Birt, C., & Yamori, Y. (2011). Effects of Docosahexaenoic Acid Supplementation on Blood Pressure, Heart Rate, and Serum Lipids in Scottish Men with Hypertension and Hypercholesterolemia. International Journal of Hypertension, 2011(), 149-155. https://doi.org/10.4061/2011/809198